Invitrogen Will Use Genetix's ClonePixFL in PD-Direct Offering | GenomeWeb
NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
The technology will be offered through Invitrogen's PD-Direct offering.
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.